Motilal Oswal Suggests Buy This Pharma Stock, Revenue Rose To Rs 52.2b, Announced 600% Dividend - Goodreturns

Motilal Oswal, the brokerage firm has recommended buy the shares of Dr Reddys Laboratories Ltd for a target price of Rs 4,800. Looking at the Current Market Price (CMP) and the target price, it has the potential of 14% gains. On Thursday, 19 May 2022, while a…

The CMP of Dr Reddy's Laboratories Ltd closed on Friday, 20 May 2022 is Rs 4,228 after gaining 7.60% in a day. As mentioned above, with the target price of Rs 4,800 set by the brokerage, investors ca… [+3198 chars]

full article...